Plasma Fibroblast

Plasma Fibroblast – Complete guide: technique, results, recovery, risks, cost. Compare verified clinics in Belgium.

Quick FAQ↘

What is plasma fibroblast treatment?

Plasma fibroblast treatment uses a pen-like electrical device to create a tiny electrical arc between the tip and the skin. The arc ionizes the surrounding air and produces controlled heat injury at the skin surface. You may see it called plasma pen, plasma fibroblasting, plasma exeresis or plasma lift.

The treatment creates a pattern of small thermal dots. The immediate effect is superficial tissue contraction; healing then triggers inflammation and collagen remodelling.

It is not platelet-rich plasma (PRP), despite the shared word “plasma.” It is also not the same as cold atmospheric plasma used in emerging dermatology research.

What can plasma fibroblast treatment realistically improve?

The best cosmetic evidence is for mild to moderate upper-eyelid skin laxity and fine periorbital wrinkles. Small studies have also investigated benign skin lesions, xanthelasma, acne, scars and other dermatologic problems.

That does not mean all of the very broad claims made by plasma-pen training academies are established. Evidence for general facial lifting, jowls, neck tightening, stretch marks or major scar correction is much thinner.

The treatment is better understood as a controlled superficial thermal procedure than as a “fibroblast activation” miracle.

Can a plasma pen replace upper blepharoplasty?

No. It can be reasonable for selected patients with limited excess eyelid skin who accept a modest result and want to avoid surgery.

It cannot remove or reposition protruding fat pads, correct significant eyelid hooding, repair muscle or tendon problems, or reproduce the degree of correction possible with surgical blepharoplasty.

A 2024 study on lateral dermatochalasis specifically emphasized patient selection and the limitations of plasma compared with surgery. If excess skin is substantial, repeated plasma treatments can create a lot of injury without solving the structural problem.

How strong is the evidence for eyelid tightening?

There is genuine clinical research, but it is still a small evidence base.

A 2022 clinical study of 56 women reported significant improvement in eyelid laxity and periorbital wrinkles after three plasma-exeresis sessions. Another trial involving 40 women also found improvement after three sessions. A 2024 study evaluated 21 patients with lateral dermatochalasis and again found benefit in selected cases.

These studies are encouraging, but they are not the same as large randomized trials directly comparing plasma fibroblasting with surgery, CO₂ laser or RF microneedling. Long-term recurrence data are also limited.

What happens during a plasma fibroblast session?

The skin is cleaned and topical anaesthetic is often applied. The operator holds the device very close to the skin and creates many small plasma arcs in a planned pattern. The tiny dots produce immediate superficial contraction and then form crusts.

Treatment around the eyes requires particular caution. The procedure may look simple on social media, but it is intentionally creating thermal injury close to delicate structures.

How much downtime should I expect?

This is not truly a “no-downtime” treatment.

Swelling can be obvious for the first few days, particularly around the eyelids. The treated dots darken and crust before separating. Social downtime is commonly around several days to two weeks, and redness or pigment change can last longer.

Do not pick the crusts to make them disappear faster. Removing them early can increase inflammation, infection and scarring risk.

What results should I expect and when do they appear?

Some contraction is visible early because of the thermal effect. Further change develops over the following weeks as the skin heals and remodels.

Published eyelid studies often used three sessions rather than one. A realistic result is mild to moderate tightening in a well-selected patient, not a surgical lift.

How long the effect lasts is less well established than the marketing often suggests. Skin ageing continues, and the published cosmetic literature does not support a universal multi-year guarantee.

What are the common side effects?

Expected short-term effects include:

  • swelling, especially around the eyes;
  • redness and tenderness;
  • multiple dark crusts at the treatment points;
  • temporary tightness, itching or burning;
  • temporary colour change while the skin heals.

Small clinical series often report few serious complications, but that should not be mistaken for proof that complications are rare. The published studies are not large enough to give trustworthy incidence percentages for uncommon problems.

What serious or long-lasting complications can occur?

Reported and biologically plausible complications include:

  • post-inflammatory hyperpigmentation, which can persist for months;
  • hypopigmentation;
  • burns from excessive energy or overlapping treatment;
  • permanent scarring or texture change;
  • infection;
  • prolonged redness or swelling;
  • eye injury during periocular treatment.

Published case reports specifically document prolonged periorbital hyperpigmentation after plasma exeresis. Another report described bilateral chemical eye injury caused by topical anaesthetic entering the eyes before a plasma-fibroblast procedure.

These are uncommon reports, not proof that the treatment is generally unsafe. They do show why a procedure that deliberately burns skin should not be treated as a casual beauty service.

Is plasma fibroblasting riskier for darker skin?

Any procedure that creates visible thermal injury can trigger post-inflammatory hyperpigmentation, and the risk generally matters more in skin that pigments easily.

This does not mean darker skin can never be treated. It means the provider should understand pigment biology, use appropriate energy, avoid overtreatment and be able to manage complications. If a clinic claims that pigment risk does not exist because the device “does not touch the skin,” that is a red flag.

Can plasma pens safely remove moles and other skin lesions?

Plasma devices have been studied for selected benign lesions, and a 2024 series reported good outcomes for benign eyelid lesions. But diagnosis comes before destruction.

A pigmented lesion that has not been medically assessed should not simply be burned away in a beauty clinic. Destroying tissue can remove the opportunity for histopathology and may delay diagnosis of melanoma or another skin cancer.

If the lesion is changing, asymmetric, irregular, bleeding, unusually pigmented or simply uncertain, see a dermatologist first.

How are plasma pens regulated?

Regulation varies by country and by the intended use of the exact device. In the United States, the FDA now has a specific Class II category for low-power electrosurgical plasma-pen devices intended for destruction of skin lesions, and specific devices have received 510(k) clearance. That does not mean every plasma pen on the market is cleared, or that clearance for lesion destruction proves effectiveness for every advertised cosmetic “lift.”

Health Canada has likewise authorized certain plasma pens for professional medical use after previously warning about unauthorized devices.

Ask for the exact device name, its regulatory status in your country and the indication for which it is being used.

How does plasma fibroblasting compare with CO₂ laser, RF microneedling and surgery?

  • Upper blepharoplasty: remains the more definitive option for significant excess eyelid skin and structural ageing.
  • Fractional or ablative CO₂ laser: has a much larger evidence base for resurfacing wrinkles, photoageing and some scars, but also has meaningful downtime and pigment risk.
  • RF microneedling: delivers energy below the skin surface and is more commonly used for texture, acne scars and mild laxity. It has its own risks and is not equivalent to plasma.
  • Non-ablative lasers/RF: usually have less crusting and downtime but produce more gradual tightening.

The best option depends on what is actually causing the problem. Fine crepey skin, true excess eyelid skin, protruding fat and brow descent are different anatomical problems and should not all be sold the same “non-surgical lift.”

What should I ask before booking plasma fibroblast treatment?

  • What exact device will be used?
  • Is it legally authorized for professional use where I live?
  • What is the practitioner's medical qualification and experience around the eyes?
  • Am I a good candidate for plasma, or would laser, RF or surgery make more sense?
  • What is the realistic downtime for my skin type?
  • How will pigmentation, infection or scarring be managed if they occur?

Plasma fibroblasting is not automatically “fake” or ineffective. Small clinical studies show that it can improve selected problems. But the gap between reasonable evidence for carefully selected patients and the sweeping claims often made online is unusually large.

Medical sources and references

  • Nemet AY, et al. Ablative radiofrequency microplasma for lateral dermatochalasis—indications and treatment recommendations. Lasers Med Sci. 2024. PMID: 39694894; PMCID: PMC11655603. https://pubmed.ncbi.nlm.nih.gov/39694894/
  • Ucar F, Unluzeybek M. Plasma Exeresis for the Treatment of Benign Eyelid Lesions: A New Surgical Approach. Ophthalmic Plast Reconstr Surg. 2024. PMID: 38427826. https://pubmed.ncbi.nlm.nih.gov/38427826/
  • Noorbakhsh M, et al. Comparing the efficacy of plasma exeresis and cryotherapy for the treatment of seborrheic keratosis: A randomized controlled trial. Skin Res Technol. 2023. PMID: 37632194. https://pubmed.ncbi.nlm.nih.gov/37632194/
  • Keloid Treatment Using Plasma Exeresis: A Pilot Trial Study. J Lasers Med Sci. 2023. PMID: 37089764. https://pubmed.ncbi.nlm.nih.gov/37089764/
  • Abdollahimajd F, Beheshti M, Moravvej H. Evaluation of the efficacy and safety of plasma exeresis in periorbital rejuvenation using the Reviscometer. J Cosmet Dermatol. 2022. PMID: 34520602. https://pubmed.ncbi.nlm.nih.gov/34520602/
  • Hassan AM, et al. Evaluation of plasma exeresis as a new technique for non surgical treatment of dermatochalasis. J Dermatolog Treat. 2022. PMID: 32698635. https://pubmed.ncbi.nlm.nih.gov/32698635/
  • Scarano A, et al. Xanthelasma palpebrarum removed with Atmospheric Plasma technique: 11-year follow up. 2021. PMID: 34281315. https://pubmed.ncbi.nlm.nih.gov/34281315/
  • A Descriptive Study on the Applications of Plasma Exeresis in Dermatology. J Clin Aesthet Dermatol. 2021. PMID: 33841619. https://pubmed.ncbi.nlm.nih.gov/33841619/
  • Periorbital postinflammatory hyperpigmentation after plasma exeresis. 2020. PMID: 32279389; PMCID: PMC7317400. https://pubmed.ncbi.nlm.nih.gov/32279389/
  • Plasma fibroblast skin tightening treatment resulting in bilateral chemical eye injury secondary to EMLA cream: a case report. 2020. PMID: 32831067. https://pubmed.ncbi.nlm.nih.gov/32831067/
  • Plasma sublimation for the treatment of xanthelasma palpebrarum. 2020. PMID: 32566950. https://pubmed.ncbi.nlm.nih.gov/32566950/
Medical Disclaimer
This article is intended for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. It is based on peer-reviewed medical research, clinical guidelines, and expert-reviewed medical literature to provide clear, reliable, and up-to-date information for patients. Always consult a qualified healthcare provider with any questions you may have regarding a medical condition or treatment.
We do not promote any specific treatment, product, or provider, and there are no conflicts of interest influencing the content.
All before-and-after photos shown on this page are licensed stock images intended for illustrative purposes only. They do not depict actual patients of the surgeons listed on our site. Results may vary based on individual anatomy and treatment plans.

Plasma Fibroblast can help with:

When is it helpful?
View Profile
Close

Plasma Fibroblast in the major cities of Belgium

No items found.